垂体后叶素联合酚妥拉明治疗肺结核咯血疗效观察

Efficacy Observation on Pituitrin Combined with Phentolamine for Hemoptysis of Pulmonary Tuberculosis

目的：探讨垂体后叶素联合酚妥拉明治疗肺结核咯血的疗效。方法：将50例肺结核咯血患者随机分为观察组和对照组各25例，对照组给予静滴垂体后叶素，观察组则联合静滴酚妥拉明，比较两组临床疗效及不良反应发生情况。结果：观察组总有效率为96.0%，显著高于对照组的72.0%（P〈0.05）；观察组不良反应发生率显著低于对照组（P〈0.05）。结论：垂体后叶素联合酚妥拉明治疗肺结核咯血可有效改善患者的临床症状，且不良反应少、安全性高，值得临床推广应用。

Objective：To investigate the efficacy of pituitrin combined with phetolamine for hemoptysis of pulmonary tuberculosis. Methods：50 cas-es patients with hemoptysis of pulmonary tuberculosis were randomly divided into observation group （25 cases） and control group （25 cases）, the control group treated by pituitrin intravenous drip, while observation group combined with phentolamine intravenous drip, compared the efficacy and occurrence of adverse reactions of two groups. Results：The total effective rate of observation group was 96.0%, which was significantly higher than 72.0%that of control group （P〈0.05）;the adverse reactions occurrence rate of observation group was significantly lower than that of control group （P〈0.05）. Conclusion：The treatment of pituitrin combined with phentolamine for hemoptysis of pulmonary tuberculosis can effectively improve the symptoms of patients, and its little adverse reactions and high safety makes it deserve clinical promotion and application.